MCK vs MDLN
MCK: A global leader in pharmaceutical distribution and healthcare technology services, connecting biopharma, providers, and patients to improve care outcomes. MDLN: Medline is a leading global manufacturer and distributor of medical supplies and clinical solutions serving healthcare providers across the care continuum.
Side-by-side fundamentals
| Metric | MCK | MDLN | Edge |
|---|---|---|---|
| Price as of 2026-10-09 close | $938.84 | $36.26 | |
| Market cap | $109.5B | $47.7B | |
| P/E as of 2026-10-09 | 25.14 | 43.00 | MCK lower |
| PEG as of 2026-10-09, 3-year EPS CAGR to FY2026 | 1.64 | n/a | |
| Net margin | +1.2% | +4.1% | MDLN higher |
| Gross margin | +3.6% | +26.4% | MDLN higher |
| Operating margin | +1.5% | +7.8% | MDLN higher |
| ROE FY2025, SEC XBRL | n/a | +10.8% | |
| ROA | +5.8% | +3.0% | MCK higher |
| Debt / equity as of 2026-09-03 | 1.29 | 1.09 | MDLN lower |
| Revenue growth (YoY) as of 2026-09-03 | +8.8% | +11.6% | MDLN higher |
| Revenue CAGR (3y) SEC XBRL | +13.4% | +10.6% | MCK higher |
| Dividend yield as of 2026-09-03 | +0.4% | n/a | |
| Dividend streak (yrs) SEC XBRL | 19 | 0 | MCK higher |
| Beta as of 2026-09-03 | 0.06 | 0.61 | |
| 1-year return as of 2026-10-09 close | +23.9% | n/a |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-09.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.